Efgartigimod as a treatment for adults with primary immune thrombocytopenia: a plain language summary of the ADVANCE IV study
Therapeutic Advances in Hematology
Published online on April 17, 2026
Abstract
Therapeutic Advances in Hematology, Volume 17, January-December 2026.
SummaryWhat is this summary about?This is a plain language summary of an article published in the scientific journal The Lancet in 2023. The ADVANCE IV study involved people living with immune thrombocytopenia, called ITP. In primary ITP your immune ...
SummaryWhat is this summary about?This is a plain language summary of an article published in the scientific journal The Lancet in 2023. The ADVANCE IV study involved people living with immune thrombocytopenia, called ITP. In primary ITP your immune ...